What are ADMA Biologics's profit margins?

ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.

Where do ADMA Biologics's ratios come from?

Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ADMA Biologics ADMA Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	61.3%+8.7pp	57.4%+5.9pp	54.7%+5.8pp	53%+6.9pp	52.6%+13.2pp
Operating margin	42.1%+9.0pp	37.5%+4.9pp	34.2%+4.2pp	32.8%+7.4pp	33.1%+17.5pp
Net margin	32.4%-12.6pp	28.8%-17.6pp	42.9%+25.1pp	44.1%+33.5pp	45%+46.3pp
EBITDA margin	43.7%+8.9pp	39.1%+4.7pp	35.8%+6.1pp	34.5%+10.4pp	34.8%+18.7pp
Free cash flow margin	21.2%+1.4pp	5.5%-20.4pp	8.3%-12.4pp	13.9%-6.3pp	19.7%+14.0pp
Returns
Return on equity	43.3%-35.2pp	35.6%-46.1pp	63.2%+27.6pp	71.2%+50.5pp	78.5%+80.9pp
Return on assets	28.1%-19.9pp	26.4%-21.9pp	43.7%+25.2pp	44.7%+35.0pp	48%+49.1pp
Return on invested capital	44.8%-25.8pp	38.6%-27.1pp	54.9%-26.0pp	72.6%+10.6pp	70.7%+33.9pp
Efficiency
Asset turnover	0.9×-0.2×	0.9×-0.1×	1×0.0×	1×+0.1×	1.1×+0.2×
Inventory turnover	1×-0.2×	1.2×-0.1×	1.2×0.0×	1.2×+0.2×	1.2×+0.2×
Liquidity
Current ratio	7×+0.4×	6.7×+0.7×	7.1×0.0×	5.3×-1.5×	6.6×+1.4×
Quick ratio	3.9×+0.6×	3.7×+0.8×	3.6×+0.4×	2.8×0.0×	3.4×+1.5×
Cash ratio	1.9×+0.5×	1.3×-0.6×	1.1×-0.8×	1.2×-0.8×	1.3×+0.5×
Leverage
Debt-to-equity	0.5×+0.5×	0.2×-0.1×	0.2×+0.1×	0×0.0×	0×0.0×
Debt-to-assets	0.3×+0.3×	0.1×0.0×	0.1×+0.1×	0×0.0×	0×0.0×
Net debt / EBITDA	0.3×+0.7×	-0×+0.1×	0.1×+0.8×	-0.5×+0.5×	-0.4×+0.4×
Interest coverage	29.7×+17.2×	26.9×+16.9×	20×+13.8×	15.3×+11.7×	12.5×+10.9×
Per Share
Book value per share	$1.63+6.6%	$1.95+35.9%	$1.76+86.1%	$1.60+106%	$1.53+135%
Valuation
Market capitalization	$2.15B-54.5%	$4.34B+7.1%	$3.5B-24.9%	$4.26B+64.4%	$4.71B+213%
Enterprise value	$2.21B-52.5%	$4.33B+7.4%	$3.52B-23.2%	$4.18B+66.3%	$4.65B+216%
Price / earnings	13×-9.8×	29.5×—	16.7×—	20.4×—	22.8×—
Price / sales	4.2×-6.1×	8.5×-1.0×	7.2×-5.0×	9×+1.1×	10.3×+4.9×
Price / book	5.5×-7.1×	9.1×-2.5×	8.1×-12.0×	10.7×-3.1×	12.6×+2.8×
EV / EBITDA	9.9×-19.2×	21.7×-5.8×	20.1×-20.2×	25.6×-6.1×	29.1×-3.1×
EV / sales	4.3×-5.8×	8.5×-1.0×	7.2×-4.8×	8.8×+1.2×	10.1×+4.9×
Free cash flow yield	5%+3.1pp	0.6%-2.1pp	1.2%-0.5pp	1.5%-1.0pp	1.9%+0.9pp
Earnings yield	7.7%+3.3pp	3.4%-1.5pp	6%+4.5pp	4.9%+3.6pp	4.4%+4.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ADMA Biologics's profit margins?: ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.
Where do ADMA Biologics's ratios come from?: Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.